Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bowel preparation plus oral rifaximin in brachytherapy for endometrial and cervical cancer
IRCT20200208046412N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rifaximin in endometrial cancer (EC) and Cervical Cancer (CC), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Sep 2019; status: completed.
02
Drugs
rifaximin
03
Conditions
endometrial cancer (EC)Cervical Cancer (CC)
Beyond the preview
Go deeper on IRCT20200208046412N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200208046412N1.